...
首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis.
【24h】

Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis.

机译:终末期肾病患者对慢性血液透析患者心率变异性的预后价值。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND:Although decreased heart rate variability (HRV) is an independent predictor of death in various populations, its prognostic value in patients with end-stage renal disease on chronic haemodialysis is unknown. METHODS:We prospectively studied 120 chronic haemodialysis patients (age 61+/-11 years; males 51%; diabetics 38%; duration of haemodialysis therapy 50+/-114 months) who underwent 24 h electrocardiography at baseline for analysis of time- and frequency-domain HRV. RESULTS:All HRV measures in the patients were significantly reduced compared with those obtained from 62 age-matched healthy subjects. During a follow-up period of 26+/-10 months, 21 patients died (17.5%); 10 from cardiac causes and 11 from non-cardiac causes (seven fatal strokes and four other causes). A Cox proportional hazards model revealed that, of the HRV measures, decreases in the triangular index (TI), very-low-frequency (0.0033-0.04 Hz) power, ultra-low-frequency (<0.0033 Hz) power (ULF) and the ratio of low-frequency (0.04-0.15 Hz) power to high-frequency (0.15-0.4 Hz) power had significant predictive value for cardiac death. None of the HRV measures, however, had predictive value for non-cardiac death, including stroke death. Even after adjustment for other univariate predictors including age, diabetes, serum albumin and coronary artery disease, the predictive value of decreased TI and ULF remained significant-adjusted relative risk (95% confidence interval) per 1 SD decrement of TI and ULF, 3.28 (1.08-9.95) and 1.92 (1.01-3.67), respectively. CONCLUSIONS:Decreases in some HRV measures, particularly those reflecting long-term variability, are independent predictors of cardiac death in chronic haemodialysis patients.
机译:背景:尽管心率变异性(HRV)下降是各个人群死亡的独立预测因素,但对于终末期肾脏疾病的慢性血液透析患者的预后价值尚不清楚。方法:我们前瞻性研究了基线时进行了24小时心电图检查的120例慢性血液透析患者(年龄61 +/- 11岁;男性51%;糖尿病患者38%;血液透析治疗的持续时间50 +/- 114个月)。频域HRV。结果:与62例年龄相匹配的健康受试者相比,患者的所有HRV测量值均显着降低。在26 +/- 10个月的随访期内,有21例患者死亡(17.5%); 10个来自心脏原因,11个来自非心脏原因(七个致命中风和四个其他原因)。 Cox比例风险模型显示,在HRV量度中,三角指数(TI),超低频(0.0033-0.04 Hz)功率,超低频(<0.0033 Hz)功率(ULF)和低频(0.04-0.15 Hz)功率与高频(0.15-0.4 Hz)功率之比对心脏死亡具有重要的预测价值。然而,没有一项HRV措施对非心源性死亡(包括中风死亡)具有预测价值。即使在调整了其他单变量预测因素(包括年龄,糖尿病,血清白蛋白和冠状动脉疾病)之后,TI和ULF下降的预测值仍然是TI和ULF每1 SD下降的相对校正风险(95%置信区间),3.28( 1.08-9.95)和1.92(1.01-3.67)。结论:某些HRV测量值的降低,特别是反映长期变异性的测量值的降低,是慢性血液透析患者心脏死亡的独立预测因子。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号